Based on our previous finding that the adaptor SH3BP2 was able to regulate KIT and MITF expression and viability on mast cells (Ainsua‐Enrich et al., 2015), we explored the ability of this protein to regulate these events in GIST. This evidence concerns the gene SH3BP2 and gastrointestinal stromal tumor.